A Correlation Study Between Iron Overload, Chelation Therapy (ICT), and Metabolic Outcomes in β-Thalassemia Major (β-TDT) Patients

被引：0
|
作者：
De Sanctis, Vincenzo [1 ]
Soliman, Ashraf [2 ]
Daar, Shahina [3 ]
Campisi, Saveria [4 ]
Tzoulis, Ploutarchos [4 ]
机构：
[1] Quisisana Hosp, Pediat & Adolescent Outpatient Clin, Ferrara, Italy
[2] Hamad Gen, Div Endocrinol, Dept Pediat, Doha, Qatar
[3] Sultan Qaboos Univ, Dept Haematol, Coll Med & Hlth Sci, Muscat, Oman
[4] UCL, Whittington Hosp, Dept Endocrinol & Diabet, London, England
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2024年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2-198
引用
收藏
页码：423 / 423
页数：1
相关论文
共 50 条
  • [1] Longitudinal Changes in Iron Overload Parameters and Iron Chelation Therapy in Young Patients with Thalassemia Major
    Kattamis, Antonis
    Stokidis, Konstantinos
    Delaporta, Polyxeni
    Dimitra, Kyriakopoulou
    Petropoulou, Theoni
    Boiu, Sorina
    Ladis, Vassilis
    BLOOD, 2011, 118 (21) : 1383 - 1383
  • [2] Serum Metabolite Profiles Are Reflective of Iron Overload in Thalassemia Major Patients on Chelation Therapy
    Sayani, Farzana
    Abdolmohammadi, Niloufar
    Lauf, Anne Marie
    Weljie, Aalim
    BLOOD, 2011, 118 (21) : 925 - 925
  • [3] The Non-adherence to iron chelation therapy ( ICT) among transfusion-dependent thalassemia ( TDT) patients in Pakistan
    Arif, Fariha
    Qazi, Zunaira
    Maqsood, Amna
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (09) : 1939 - 1939
  • [4] Transfusional Iron Overload and Iron Chelation Therapy in Thalassemia Major and Sickle Cell Disease
    Marsella, Maria
    Borgna-Pignatti, Caterina
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (04) : 703 - +
  • [5] Iron chelation therapy in thalassemia major
    Guven, sirin
    Erdogan, Makbule
    MEDICAL JOURNAL OF BAKIRKOY, 2007, 3 (04) : 125 - 129
  • [6] A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with ß-thalassemia major
    Elalfy, Mohsen S.
    Massoud, Walid
    Elsherif, Nayera H.
    Labib, Jonair H.
    Elalfy, Omar M.
    Elaasar, Safaa
    von Mackensen, Sylvia
    PEDIATRIC BLOOD & CANCER, 2012, 58 (06) : 910 - 915
  • [7] Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia in the Believe Trial
    Hermine, Olivier
    Cappellini, Maria Domenica
    Taher, Ali T.
    Coates, Thomas D.
    Viprakasit, Vip
    Voskaridou, Ersi
    Lal, Ashutosh
    Liew, Hong Keng
    Perrotta, Silverio
    Khelif, Abderrahim
    Kattamis, Antonis
    Shetty, Jeevan K.
    Zhang, George
    Tian, Yu
    Miteva, Dimana
    Zinger, Tatiana
    Tang, Derek
    Backstrom, Jay T.
    Porter, John B.
    BLOOD, 2020, 136
  • [8] In search of the optimal iron chelation therapy for patients with thalassemia major
    Berdoukas, Vasilios
    Wood, John
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 5 - 8
  • [9] Clinical Effectiveness of Iron Chelation Therapies in Syrian Patients with β Thalassemia Major: Suboptical Clinical Outcomes and High Prevalence of Iron Overload
    Lama, Youssef A.
    Touma, Hanan
    AlKeba, Khawla
    Maksoud, Osama
    BLOOD, 2013, 122 (21)
  • [10] IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR
    OLIVIERI, NF
    BRITTENHAM, GM
    MATSUI, D
    BERKOVITCH, M
    BLENDIS, LM
    CAMERON, RG
    MCCLELLAND, RA
    LIU, PP
    TEMPLETON, DM
    KOREN, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14): : 918 - 922
12345